FR2306689A1 - Medicament pour le traitement de l'hyperlipemie, comprenant du l-ascorbate-2-sulfate de sodium - Google Patents

Medicament pour le traitement de l'hyperlipemie, comprenant du l-ascorbate-2-sulfate de sodium

Info

Publication number
FR2306689A1
FR2306689A1 FR7610294A FR7610294A FR2306689A1 FR 2306689 A1 FR2306689 A1 FR 2306689A1 FR 7610294 A FR7610294 A FR 7610294A FR 7610294 A FR7610294 A FR 7610294A FR 2306689 A1 FR2306689 A1 FR 2306689A1
Authority
FR
France
Prior art keywords
hyperlipemia
ascorbate
sulphate
sodium
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7610294A
Other languages
English (en)
Other versions
FR2306689B1 (fr
Inventor
Eiichi Hayashi
Yasuo Fujimoto
Tsuyoshi Kinoshita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Chemiphar Co Ltd
Original Assignee
Nippon Chemiphar Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Chemiphar Co Ltd filed Critical Nippon Chemiphar Co Ltd
Publication of FR2306689A1 publication Critical patent/FR2306689A1/fr
Application granted granted Critical
Publication of FR2306689B1 publication Critical patent/FR2306689B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/62—Three oxygen atoms, e.g. ascorbic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FR7610294A 1975-04-08 1976-04-08 Medicament pour le traitement de l'hyperlipemie, comprenant du l-ascorbate-2-sulfate de sodium Granted FR2306689A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4185575 1975-04-08

Publications (2)

Publication Number Publication Date
FR2306689A1 true FR2306689A1 (fr) 1976-11-05
FR2306689B1 FR2306689B1 (fr) 1978-11-17

Family

ID=12619855

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7610294A Granted FR2306689A1 (fr) 1975-04-08 1976-04-08 Medicament pour le traitement de l'hyperlipemie, comprenant du l-ascorbate-2-sulfate de sodium

Country Status (6)

Country Link
DE (1) DE2615372A1 (fr)
FR (1) FR2306689A1 (fr)
GB (1) GB1489734A (fr)
IL (1) IL49355A (fr)
NL (1) NL7603698A (fr)
ZA (1) ZA762124B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0006305A1 (fr) * 1978-06-05 1980-01-09 American Home Products Corporation Dérivés de l'acide 4,5-dihydro-4-oxofuranne-2-carboxylique, en particulier pour l'application comme agents hypolipémiques, procédés pour leur préparation, compositions pharmaceutiques les contenant, tétrahydropyranne-2,3,5-triones servant à préparer lesdits dérivés et un procédé pour la préparation de tétrahydropyranne-2,3,5-triones

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2249667A1 (fr) * 1973-11-07 1975-05-30 Kumiai Chemical Industry Co

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2249667A1 (fr) * 1973-11-07 1975-05-30 Kumiai Chemical Industry Co

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0006305A1 (fr) * 1978-06-05 1980-01-09 American Home Products Corporation Dérivés de l'acide 4,5-dihydro-4-oxofuranne-2-carboxylique, en particulier pour l'application comme agents hypolipémiques, procédés pour leur préparation, compositions pharmaceutiques les contenant, tétrahydropyranne-2,3,5-triones servant à préparer lesdits dérivés et un procédé pour la préparation de tétrahydropyranne-2,3,5-triones

Also Published As

Publication number Publication date
NL7603698A (nl) 1976-10-12
FR2306689B1 (fr) 1978-11-17
GB1489734A (en) 1977-10-26
DE2615372A1 (de) 1976-10-21
IL49355A (en) 1979-09-30
IL49355A0 (en) 1976-06-30
ZA762124B (en) 1977-04-27

Similar Documents

Publication Publication Date Title
BE837472A (fr) Inhalateur pour l'administration de remedes pulverulents
BE876157Q (fr) Medicament pour le traitement de l'acne
BE865156A (fr) Compositions pharmaceutiques pour le traitement des depressions
FR2287435A1 (fr) Procede de preparation de cyclohexane-diones-1,3 et d'alkyl-6-dihydro-3,4-pyranones-2
FR2341315A1 (fr) Medicaments pour le traitement des neuropathies
FR2310769A1 (fr) Medicament pour le traitement de l'alopecia seborrhoeica
BE852095A (fr) Composition pharmaceutique pour le traitement de la leucemie et de tumeurs
FR2311553A1 (fr) Medicament pour le traitement de la schizophrenie
FR2332965A1 (fr) Formulations d'uree-polyphosphate-potassium pour le traitement du feuillage
FR2310751A1 (fr) Nouveaux medicaments utiles pour le traitement de la dysenterie du porc
FR2334362A1 (fr) Composition pharmaceutique pour le traitement de l'hyperuricemie
FR2310770A1 (fr) Medicament pour le traitement de l'alopecia areata
FR2306689A1 (fr) Medicament pour le traitement de l'hyperlipemie, comprenant du l-ascorbate-2-sulfate de sodium
BE837294A (fr) Preparations pharmaceutiques pour le traitement des troubles de la circulation
FR2310767A1 (fr) Medicament pour le traitement de l'alopecia chronica diffusa
FR2515961B1 (fr) Preparations medicamenteuses contenant un derive d'acide tetraiodothyrocarboxylique notamment pour le traitement de l'hypercholesterolemie
FR2310768A1 (fr) Medicament pour le traitement de l'alopecia senilis
BE860239A (fr) Preparation medicinale pour le traitement des neoformations malignes
RO65965A2 (fr) Composition medicamenteuse pour le traitement d'ulcere gastroduodenel
BE829024A (fr) Compositions pharmaceutiques pour le traitement de l'hydropisie
BE791253A (fr) Nouvelles preparations pharmaceutiques pour le traitement de l'hypertonie
BE854265A (fr) Medicament pour le traitement d'hyperliporoteinemies primaires et secondaires
BE892781A (fr) Nouvelles compositions pharmaceutiques pour le traitement du diabete
FR2326921A1 (fr) Nouveaux 5-nitro-imidazoles utiles comme medicame nts pour le traitement d'infections microbiennes
PT66619A (fr) Procede pour la preparation de verbenone,myrthenal et pinocarveolo et son emploi therapeutique

Legal Events

Date Code Title Description
ST Notification of lapse